Astria Therapeutics (ATXS) News Today $6.28 -0.39 (-5.85%) Closing price 04:00 PM EasternExtended Trading$6.28 0.00 (-0.08%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ATXS Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Astria Therapeutics (ATXS) to Release Earnings on MondayAugust 5 at 10:27 AM | marketbeat.comAstria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)August 4, 2025 | businesswire.comAstria Therapeutics Announces Positive Initial Results from Long-Term Navenibart Trial in HAE PatientsAugust 1, 2025 | msn.comAstria Therapeutics, Inc. (NASDAQ:ATXS) Given Average Recommendation of "Buy" by BrokeragesAugust 1, 2025 | americanbankingnews.comAstria Therapeutics, Inc. (NASDAQ:ATXS) Receives Consensus Rating of "Buy" from AnalystsAugust 1, 2025 | marketbeat.comAstria Therapeutics to Present at Upcoming 2025 US Hereditary Angioedema Association National SummitJuly 7, 2025 | finance.yahoo.comAstria Therapeutics, Inc. (NASDAQ:ATXS) Given Average Recommendation of "Buy" by AnalystsJuly 7, 2025 | marketbeat.comAstria Therapeutics (NASDAQ:ATXS) Shares Pass Above Fifty Day Moving Average - Should You Sell?July 5, 2025 | marketbeat.comAstria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Seeking AlphaJuly 3, 2025 | seekingalpha.comAstria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635 (c) (4) - MorningstarJuly 3, 2025 | morningstar.comMATXS - Astria Therapeutics Inc Key Metrics - MorningstarJuly 2, 2025 | morningstar.comMAstria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)July 2, 2025 | businesswire.comAstria Therapeutics Inc News (ATXS) - Investing.comJune 25, 2025 | investing.comAstria Therapeutics (NASDAQ:ATXS) Shares Cross Above Fifty Day Moving Average - Here's WhyJune 21, 2025 | marketbeat.comAstria Therapeutics' (ATXS) Buy Rating Reiterated at HC WainwrightJune 13, 2025 | marketbeat.comAstria Therapeutics, Inc. (NASDAQ:ATXS) Receives Average Recommendation of "Buy" from AnalystsJune 12, 2025 | marketbeat.comEquities Analysts Set Expectations for ATXS FY2026 EarningsJune 10, 2025 | marketbeat.comAstria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology Annual CongressJune 6, 2025 | businesswire.comAstria Therapeutics at Jefferies Conference: Strategic Pipeline InsightsJune 6, 2025 | investing.comAstria Therapeutics to Present at Upcoming Jefferies Global Healthcare ConferenceMay 28, 2025 | finance.yahoo.comAstria Therapeutics to Present at Upcoming C1 Inhibitor Deficiency and Angioedema WorkshopMay 23, 2025 | businesswire.comAstria Therapeutics to Present at Upcoming Eastern Allergy ConferenceMay 22, 2025 | businesswire.comAstria Therapeutics, Inc. (NASDAQ:ATXS) Shares Sold by VR Adviser LLCMay 22, 2025 | marketbeat.comVestal Point Capital LP Acquires 180,000 Shares of Astria Therapeutics, Inc. (NASDAQ:ATXS)May 21, 2025 | marketbeat.comPatient Square Capital LP Boosts Holdings in Astria Therapeutics, Inc. (NASDAQ:ATXS)May 16, 2025 | marketbeat.comAstria Therapeutics Shares Rise Following Update on In-Development DrugsMay 13, 2025 | marketwatch.comAstria Therapeutics Reports First Quarter 2025 Financial Results and Provides a Corporate UpdateMay 13, 2025 | businesswire.comFcpm Iii Services B.V. Purchases New Position in Astria Therapeutics, Inc. (NASDAQ:ATXS)May 11, 2025 | marketbeat.comIs Astria Therapeutics, Inc. (ATXS) the Low Risk High Reward Stock Set to Triple by 2030?May 10, 2025 | insidermonkey.comRaymond James Financial Inc. Buys Shares of 79,044 Astria Therapeutics, Inc. (NASDAQ:ATXS)May 9, 2025 | marketbeat.comInvesco Ltd. Has $161,000 Holdings in Astria Therapeutics, Inc. (NASDAQ:ATXS)May 6, 2025 | marketbeat.comCantor Fitzgerald Comments on ATXS FY2025 EarningsMay 3, 2025 | marketbeat.comAstria Therapeutics (ATXS) to Release Quarterly Earnings on ThursdayMay 3, 2025 | marketbeat.comAstria Therapeutics reports progress in HAE drug trialMay 2, 2025 | investing.comAstria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)May 2, 2025 | businesswire.comAstria Therapeutics (NASDAQ:ATXS) Stock Rating Upgraded by Cantor FitzgeraldMay 2, 2025 | marketbeat.comAstria Therapeutics Announces Publication of Navenibart Phase 1a Healthy Subject Results in the Annals of Allergy, Asthma & ImmunologyMay 1, 2025 | finance.yahoo.comAdage Capital Partners GP L.L.C. Sells 54,743 Shares of Astria Therapeutics, Inc. (NASDAQ:ATXS)May 1, 2025 | marketbeat.comCantor Fitzgerald Initiates Coverage of Astria Therapeutics (ATXS) with Overweight RecommendationApril 30, 2025 | msn.comAstria Therapeutics, Inc. (NASDAQ:ATXS) Given Consensus Recommendation of "Buy" by BrokeragesApril 25, 2025 | marketbeat.comRaymond James Financial Inc. Takes $707,000 Position in Astria Therapeutics, Inc. (NASDAQ:ATXS)April 7, 2025 | marketbeat.comAstria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)April 2, 2025 | businesswire.comAstria Therapeutics, Inc. (NASDAQ:ATXS) Receives Consensus Recommendation of "Buy" from BrokeragesMarch 30, 2025 | marketbeat.comLifesci Capital Issues Negative Estimate for ATXS EarningsMarch 15, 2025 | marketbeat.comWhat is HC Wainwright's Forecast for ATXS Q1 Earnings?March 15, 2025 | marketbeat.comWedbush Reduces Earnings Estimates for Astria TherapeuticsMarch 15, 2025 | marketbeat.comAstria Therapeutics price target raised to $28 from $27 at WedbushMarch 12, 2025 | markets.businessinsider.comAstria Therapeutics (NASDAQ:ATXS) Given Buy Rating at HC WainwrightMarch 12, 2025 | marketbeat.comWedbush Keeps Their Buy Rating on Astria Therapeutics (ATXS)March 12, 2025 | markets.businessinsider.comAstria Therapeutics (ATXS) Gets a Buy from WedbushMarch 12, 2025 | markets.businessinsider.com Get Astria Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ATXS and its competitors with MarketBeat's FREE daily newsletter. Email Address ATXS Media Mentions By Week ATXS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ATXS News Sentiment▼0.570.38▲Average Medical News Sentiment ATXS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ATXS Articles This Week▼22▲ATXS Articles Average Week Get Astria Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ATXS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Schrodinger News Today Dyne Therapeutics News Today Evotec News Today Janux Therapeutics News Today Travere Therapeutics News Today ANI Pharmaceuticals News Today Aurinia Pharmaceuticals News Today WAVE Life Sciences News Today 89BIO News Today Vera Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ATXS) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredNew Federal Land Rush About to Start?A $100 Trillion Wealth Shift Is Already Underway Lithium. Oil. Gold. Trillions in U.S. resources are being ...Stansberry Research | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Astria Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Astria Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ATXS Stock Alerts